AVITA Medical (RCEL) Asset Writedowns and Impairment (2019 - 2021)
AVITA Medical (RCEL) posted Asset Writedowns and Impairment of $19000.0 for Q3 2021, up 480.0% on a QoQ basis from -$5000.0 in Q4 2020, and up 124.68% year-over-year from $8456.6 in Q3 2020.
AVITA Medical (RCEL) Asset Writedowns and Impairment (2019 - 2021) Analysis & Trends
AVITA Medical's Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at $19000.0 for Q3 2021.
- Quarterly Asset Writedowns and Impairment rose 124.68% year-over-year to $19000.0 in Q3 2021, while the trailing twelve-month figure through Dec 2023 was $14000.0 (changed N/A YoY) and the FY2023 annual result came in at $4000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment was $19000.0 for Q3 2021 at AVITA Medical, up from -$5000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $19000.0 in Q3 2021 and bottomed at -$77000.0 in Q3 2020.
- A 3-year average of -$8800.0 and a median of $8000.0 in 2019 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2020 — Asset Writedowns and Impairment plunged 1062.5% — and 2021, when it jumped 124.68%.
- AVITA Medical's Asset Writedowns and Impairment stood at $11000.0 in 2019, then slumped by 145.45% to -$5000.0 in 2020, then soared by 480.0% to $19000.0 in 2021.
- Business Quant data shows RCEL's Asset Writedowns and Impairment at $19000.0 in Q3 2021, -$5000.0 in Q4 2020, and -$77000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 19,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Dec 31, 2020 | -5,000.00 |
| Dec 31, 2020 | -5,000.00 |
| Sep 30, 2020 | -77,000.00 |
| Sep 30, 2020 | -77,000.00 |
| Dec 31, 2019 | 11,000.00 |
| Dec 31, 2019 | 11,000.00 |
| Sep 30, 2019 | 8,000.00 |
| Sep 30, 2019 | 8,000.00 |